Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Nuclear factor kappaB activity determines the sensitivity of kidney epithelial cells to apoptosis: implications for mercury-induced renal failure.

Authors: Dieguez-Acuña, Francisco J; Polk, William W; Ellis, Maureen E; Simmonds, P Lynne; Kushleika, John V; Woods, James S

Published In Toxicol Sci, (2004 Nov)

Abstract: Nuclear factor kappa B (NF-kappaB) is a thiol-dependent transcriptional factor that promotes cell survival and protects cells from apoptotic stimuli. Numerous studies have demonstrated increased sensitivity to apoptosis associated with inhibition of NF-kappaB activation in various cell types. We have previously demonstrated that mercuric ion (Hg(2+)), one of the strongest thiol-binding agents known, impairs NF-kappaB activation and DNA binding at low microM concentrations in kidney epithelial cells. In the present studies we investigated the hypothesis that inhibition of NF-kappaB activation by Hg(2+) and other selective NF-kappaB inhibitors would increase the sensitivity of kidney epithelial (NRK52E) cells to apoptogenic agents to which these cells are normally resistant. Fewer than 10% of untreated cells in culture were found to be apoptotic when evaluated by DNA fragmentation (TUNEL) assay. Treatment of cells with Hg(2+) in concentrations up to 5 microM or with tumor necrosis factor-alpha (TNF) (300 units/ml) did not significantly increase the proportion of apoptotic cells, compared with untreated controls. However, when TNF was given following Hg(2+) pretreatment (0.5 to 5 microM for 30 min), the proportion of cells undergoing apoptosis increased by 2- to 6-fold over that seen in untreated controls. Kidney cells pretreated with specific NF-kappaB inhibitors (Bay11-7082 or SN50) prior to TNF also showed a significant increase in apoptosis. Increased sensitivity to apoptotic cell death following these treatments was significantly attenuated in cells transfected with a p65 expression vector. In studies in vivo, rats pretreated by intraperitoneal injection with Hg(2+) (0.75 mg/kg) 18 h prior to administration of bacterial lipopolysaccharide (LPS) (10 mg/kg) displayed impaired NF-kappaB activation and an increased mitochondrial cytochrome c release in kidney cortical cells. These findings are consistent with the view that prevention of NF-kappaB activity in vitro or in vivo enhances the sensitivity of kidney cells to apoptotic stimuli to which these cells are otherwise resistant. Since apoptosis is known to play a seminal role in the pathogenesis of renal failure caused by toxicant injury to tubular cells, the present findings suggest that inhibition of NF-kappaB activity may define a molecular mechanism underlying the pathogenesis of Hg(2+) toxicity in kidney cells.

PubMed ID: 15282405 Exiting the NIEHS site

MeSH Terms: Apoptosis/drug effects*; Calcium-Binding Proteins/genetics; Calcium-Binding Proteins/metabolism; Cell Line; Dose-Response Relationship, Drug; Drug Combinations; Epithelial Cells/drug effects; Epithelial Cells/metabolism; Epithelial Cells/pathology; In Situ Nick-End Labeling; Injections, Intraperitoneal; Kidney Cortex/drug effects; Kidney Cortex/immunology; Kidney/drug effects*; Kidney/metabolism; Kidney/pathology; Lipopolysaccharides/pharmacology; Membrane Glycoproteins/genetics; Membrane Glycoproteins/metabolism; Mercury/administration & dosage; Mercury/toxicity*; NF-kappa B*/antagonists & inhibitors; NF-kappa B*/biosynthesis; NF-kappa B*/pharmacology; Nerve Tissue Proteins/genetics; Nerve Tissue Proteins/metabolism; Nitriles/pharmacology; Peptides/pharmacology; Renal Insufficiency/chemically induced*; Renal Insufficiency/metabolism; Renal Insufficiency/pathology; Sulfones/pharmacology; Synaptotagmin I; Synaptotagmins; Transfection; Tumor Necrosis Factor-alpha/pharmacology

to Top